Table 2.
Structure, processing and enzymatic activity | Expression, localisation and function | References | |
---|---|---|---|
TbMCA1/4 | S replaces the predicted catalytic C but a C is located immediately adjacent. Absence of peptidase activity after R/D/N/K when TbMCA4 was expressed in S. cerevisiae or in E. coli. |
TbMCA4 induced mitochondrial dysfunction, clonal death and growth inhibition when expressed in S. cerevisiae. Nuclear localisation for TbMCA4. |
[13,31] |
TbMCA2/3/5 | No processing in vivo but autoprocessing for TbMCA2 after K55 and K268 in E. coli with calcium. Class III WW domain in N-terminus of TbMCA2/3 and in C-terminus of TbMCA5. TbMCA2 proteolytic activity: R/K-specific, Ca2+ dose-dependent and processing not required. Sensitive to leupeptin, antipain, TLCK and component with R in P1 position but insensitive to E64 inhibitor. |
Expression in the BSF but not in the PCF for TbMCA2/3 and in both forms for TbMCA5. No loss-of-function phenotype detected for the triple null mutants (Δmca2/3Δmca5). Triple RNAi induced a rapid growth arrest and a dysregulation of cytokinesis. Colocalisation of TbMCA2/3/5 with RAB11-positive endosome but no further data support involvement of TbMCAs in cell trafficking. |
[30,44] |
TcMCA3/5 |
TcMCA3 gene is present in 16 copies and TcMCA5 in a single copy in the T. cruzi genome. Q/P/Y rich region in the C-terminus of TcMCA5. Caspase-like activity concomitant with TcMCA3 nuclar relocalisation upon (FHS)-induced cell death. |
Expression of TcMCA5 in epimastigote form. Expression of TcMCA3 in the four major stages of development. Cytoplasmic localisation and migration into the nucleus upon FHS treatment. Epimastogotes over-expressing TcMCA5 are more sensitive to (FHS)-induced cell death. |
[34] |